Fiomi Diagnostic´s vision is to bring game-changing products to the professional Point of Care market by exploiting a microfluidic technology for lateral flow immunoassays which provides superlative assay performance in a cost-effective format. The Forecast Technology enables picomolar sensitivity for whole-blood In Vitro diagnostic immunoassays at the Point of Care. The technology is based on a microstructured plastic chip which provides a highly repeatable flow of fluid in lateral flow assays and an efficient fluorescence detection system providing quantitative test results.